Business Context and Reporting Period
This Form 8-K Current Report was filed by TherapeuticsMD, Inc. on September 25, 2019. The filing serves as a Regulation FD disclosure to furnish an investor presentation (Exhibit 99.1) intended for use in meetings with investors and analysts. The company is incorporated in Nevada and its common stock trades on The Nasdaq Stock Market LLC under the symbol TXMD.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a cover for an attached presentation and does not contain a standalone financial statement or tabular data within the provided text.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The report solely announces the availability of an investor presentation.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information furnished, including the attached presentation, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, the information is not subject to the liabilities of that section and will not be incorporated by reference into other filings unless expressly stated. No specific guidance, outlook, or risk factors are enumerated in the text of this 8-K.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 (Investor Presentation dated September 25, 2019) for actual financial data and strategic updates, as the 8-K text itself contains no metrics.
- Confirm that the presentation is subject to modification and is not a formal filing under Section 18 of the Exchange Act.
- Note the reporting date of September 25, 2019 for any time-sensitive data referenced in the attached exhibit.